ArticleNAR cancer2021
Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors.
Amrita Sule et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papercites it
ArticleNAR cancer2021
Amrita Sule et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.